Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism

被引:73
作者
Hussein, WI
Green, R
Jacobsen, DW
Faiman, C
机构
[1] Cleveland Clin Fdn, Dept Endocrinol, Cleveland, OH 44195 USA
[2] Univ Calif Davis, Davis, CA 95616 USA
关键词
D O I
10.7326/0003-4819-131-5-199909070-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hyperhomocysteinemia is an independent risk factor for coronary, peripheral, and cerebrovascular disease. Elevated plasma homocysteine levels were described in a preliminary report on primary hypothyroidism. Objective: To determine whether restoration of euthyroidism by L-thyroxine replacement therapy would reduce or normalize plasma homocysteine levels. Design: Prospective cohort study. Setting: Outpatient endocrinology department of a tertiary center. Patients: 14 patients (10 women and 4 men; 25 to 77 years of age): 4 with newly diagnosed chronic (Hashimoto) hypothyroidism and 10 who had been rendered acutely hypothyroid (thyroid-stimulating hormone level > 25 mU/L) by total thyroidectomy for thyroid carcinoma. Measurements: Total plasma homocysteine levels were measured at baseline and 3 to 9 months later, after euthyroidism had been attained by L-thyroxine replacement therapy. Results: Median baseline plasma homocysteine levels in both sexes (women, 11.65 mu mol/L [range, 7.2 to 26.5 mu mol/ L]; men, 15.1 mu mol/L [range, 14.1 to 16.3 mu mol/L]) were higher (P = 0.002) than those in healthy female (n = 35) and male (n = 36) volunteers (women, 7.52 mu mol/L [range, 4.3 to 14.0 mu mol/L]; men, 8.72 mu mol/L [range, 5.94 to 14.98 mu mol/L]). Eight patients (57%) had baseline plasma homocysteine levels that exceeded the upper limit of sex-specific reference ranges. Upon attainment of euthyroidism, all patients had a diminution in plasma homocysteine levels. The median overall change of -5.5 mu mol/L (range, -15.4 to -1.8 mu mol/L) corresponds to a difference of -44% (range, -58% to -13%) (P < 0.001). Homocysteine levels returned to normal in 7 of the 8 patients with elevated pretreatment values. Conclusions: Hypothyroidism may be a treatable cause of hyperhomocysteinemia, and elevated plasma homocysteine levels may be an independent risk factor for the accelerated atherosclerosis seen in primary hypothyroidism.
引用
收藏
页码:348 / 351
页数:4
相关论文
共 20 条
  • [1] LIPOPROTEIN AND APOLIPOPROTEIN LEVELS IN SUBCLINICAL HYPOTHYROIDISM - EFFECT OF LEVOTHYROXINE THERAPY
    AREM, R
    PATSCH, W
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (10) : 2097 - 2100
  • [2] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES
    BOUSHEY, CJ
    BERESFORD, SAA
    OMENN, GS
    MOTULSKY, AG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13): : 1049 - 1057
  • [3] CAMP VM, 1983, CLIN CHEM, V29, P642
  • [4] HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE
    CLARKE, R
    DALY, L
    ROBINSON, K
    NAUGHTEN, E
    CAHALANE, S
    FOWLER, B
    GRAHAM, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) : 1149 - 1155
  • [5] METHIONINE METABOLISM IN MAMMALS
    FINKELSTEIN, JD
    [J]. JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 1990, 1 (05) : 228 - 237
  • [6] Plasma homocysteine as a risk factor for vascular disease - The European concerted action project
    Graham, IM
    Daly, LE
    Refsum, HM
    Robinson, K
    Brattstrom, LE
    Ueland, PM
    PalmaReis, RJ
    Boers, GHJ
    Sheahan, RG
    Israelsson, B
    Uiterwaal, CS
    Meleady, R
    McMaster, D
    Verhoef, P
    Witteman, J
    Rubba, P
    Bellet, H
    Wautrecht, JC
    deValk, HW
    Luis, ACS
    ParrotRoulaud, FM
    Tan, KS
    Higgins, I
    Garcon, D
    Medrano, MJ
    Candito, M
    Evans, AE
    Andria, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22): : 1775 - 1781
  • [7] GREEN R, 1995, IRISH J MED SCI S15, V164, P27
  • [8] GRYTTING G, 1957, ACTA MED SCAND, V157, P169
  • [9] JACOBSEN DW, 1994, CLIN CHEM, V40, P873
  • [10] FOLIC ACID CLEARANCES + BASAL SERUM FOLATE LEVELS IN PATIENTS WITH THYROID DISEASE
    LINDENBAUM, J
    KLIPSTEIN, FA
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1964, 17 (06) : 666 - &